Roth Capital maintains VersaBank at Buy, raises price target to $32 from $28

Roth Capital kept its Buy rating on VersaBank but increased its price target to $32 from $28, a 14.3% rise. This target suggests a 5.9% downside from the Nov 13 close of $34.02.

Original reporting
Published Nov 16, 2026, 2:26 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 16, 2026, 2:31 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Roth Capital maintains VersaBank at Buy, raises price target to $32 from $28 — source image
Decision brief

The 30-second read

Med
01

Why it matters

The new target of $32 is still below the recent close of $34.02, suggesting the stock may experience selling pressure as investors reassess valuation.

02

Market read

A modest analyst upgrade with a lower-than-current price target, likely prompting short-term downside pressure.

03

What to watch

Potential upcoming earnings or macro data could shift sentiment beyond the analyst's target.

Relevance 5/10Novelty 6/10Timing: today

Background

VersaBank is a Canadian bank listed on the Toronto Stock Exchange. Analyst price target changes are common but can influence short-term trading.

Market effects

Minimal impact on the Canadian banking sector; only reflects a single analyst view.

Limited to investors tracking Canadian banks and the specific stock.

Low; does not affect broader market trends.

Counterpoint

Some investors may view the target raise as a sign of undervaluation and hold despite short-term pressure.

Key entities

  • Roth Capital

    Equity research firm that issued the price target update.

  • VersaBank

    Canadian bank (TSX: VSB) subject of the price target change.

Related articles

$VBNKMed

Versabank Surpasses Target of US$1 Billion in Additional U.S. Structured Receivable Program Fundings for Fiscal 2026; Achieves Record Quarterly Growth for Total Assets

VersaBank (TSX: VBNK, NASDAQ: VBNK) exceeded its US$1 billion target for U.S. Structured Receivable Program (SRP) fundings in fiscal 2026, reporting record quarterly asset growth of C$969 million. The bank attributes this to the success of its Real-Time SRP, particularly in the U.S. and Canada. VersaBank aims to add C$7 billion in SRP fundings by the end of 2027. The company will release full financial results on January 7, 2027.

$VBNKMedAI 8/10

VersaBank Receives Canadian Finance Minister Approval for Reorganization

VersaBank (TSX: VBNK, NASDAQ: VBNK) received approval from Canada's Finance Minister for its planned reorganization into a U.S. bank framework. The move, pending Federal Reserve approval, aims to realign the company's corporate structure and is expected to complete by October 2026. VersaBank operates in digital banking and cybersecurity.

$VBNKMed

VersaBank (VBNK) Q3 2026 Earnings Call Transcript

VersaBank (VBNK) reported Q3 2026 earnings with total revenue of CAD 38.8 million, up 23% YoY, and net income of CAD 10.1 million, up 53% YoY. Growth was driven by the U.S. Structured Receivable Program (SRP), which contributed nearly 25% of digital banking revenue. Total assets reached CAD 7.2 billion, and the company aims for significant growth in FY 2027, including a target of US$3 billion in U.S. SRP fundings.